Skip to content

Snare-assisted POEM for Treatment of Esophageal Achalasia

Safety, Efficacy and Cost-effectiveness of Snare-assisted POEM for Treatment of Esophageal Achalasia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02999451
Enrollment
75
Registered
2016-12-21
Start date
2017-05-01
Completion date
2019-12-31
Last updated
2020-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Achalasia

Keywords

Peroral endoscopic myotomy, Snare, Endoscopic knife, Esophageal Achalasia

Brief summary

POEM is a new intervention for the treatment of achalasia and has been reported to relieve the dysphagia symptom effectively. Although the cost of POEM method is less than the method of Laparoscopic Heller Myotomy and Fundoplication, it is still of an economic burden for the patients with achalasia. In this trial, investigators plan to use snare to assist POEM procedure, to observe the safety, efficacy and cost-effectiveness of this method, compared with other knifes-assisted procedure.

Interventions

DEVICEsnare-assisted POEM

POEM is performed by using a snare which is retracted into the sheath to expose the tip, leaving a 1-2mm length for operation. 1. After submucosal injection, an initial 2-cm mucosal incision is made by a snare in the posterior esophageal wall. 2. A submucosal tunnel from the esophagus to the gastric cardia is created using a snare. 3. Full-thickness myotomy is performed and extended 2-3 cm beyond the esophagogastric junction (EGJ) using a snare. 4. The mucosal incision is closed with endoclips.

DEVICEknife-assisted POEM

POEM is performed by using a conventional endoscopic knife. 1. After submucosal injection, an initial 2-cm mucosal incision is made by a knife in the posterior esophageal wall. 2. A submucosal tunnel from the esophagus to the gastric cardia is created using a knife. 3. Full-thickness myotomy is performed and extended 2-3 cm beyond the esophagogastric junction (EGJ) using a knife. 4. The mucosal incision is closed with endoclips.

Sponsors

First Affiliated Hospital, Sun Yat-Sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18-70 years * Diagnosed as achalasia base on high resolution manometry, barium esophagram and Upper endoscopy * Signed written informed consent

Exclusion criteria

* ASA class \> Ⅲ * Previous endoscopic or surgical treatment for achalasia * Esophageal malignancy * Pregnant

Design outcomes

Primary

MeasureTime frameDescription
Clinical success rates12 months after treatmentClinical success is defined as a post-POEM Eckardt score ≤3 without additional treatment (Eckardt AJ et al, Nat Rev Gastroenterol Hepatol 2011).

Secondary

MeasureTime frameDescription
Procedure timePOEM procedureProcedure time is measured from the start of submucosal injection until mucosal entry closure.
The volume of intraoperative bleedingPOEM procedure
The use of hemostatic forcepsPOEM procedure
Postoperative pain requiring the use of tramadolThrough hospital stay after procedure, an average of 2-7 daysPain related to POEM procedure requiring the use of tramadol pain medication.
The length of postoperative hospital stayThrough hospital stay after procedure, an average of 2-7 daysc
Procedure-related adverse eventsbaseline to 12 months after treatmentAdverse events are defined and graded according to the American Society for Gastrointestinal Endoscopy lexicon (Cotton PB et al, Gastrointest Endosc 2010). Incidental findings of pneumoperitoneum, pneumothorax, pneumomediastinum, pleural effusion on postoperative imaging, and subcutaneous emphysema were documented while not considered as adverse events.
Eckardt scorebaseline, 3 months and 12 months after treatmentThe Eckardt score assesses the severity of achalasia symptoms by combining the sum of symptom frequency scores for dysphagia, regurgitation, and chest pain and a weight loss score. Each component can be graded from 0 to 3 points. The total range is 0 to 12, with higher scores indicating more severe symptoms (Eckardt AJ et al, Nat Rev Gastroenterol Hepatol 2011).
Manometry parametersbaseline and 3 months after treatmentManometry parameters include lower esophageal sphincter (LES) pressure and integrated relaxation pressure (IRP) on high resolution manometry.
Maximum esophageal diameter on barium esophagrambaseline and 3 months after treatment
Gastroesophageal reflux disease questionnaire (GerdQ) scorebaseline, 3 months and 12 months after treatmentThe GerdQ has been developed as a tool to facilitate the symptom-based diagnosis of GERD. Scores ranging from 0 to 3 were applied for the four positive predictors (heartburn, regurgitation, sleep disturbance due to reflux symptoms and use of over-the-counter medications for reflux symptoms) and from 3 to 0 for two negative predictors (epigastric pain and nausea). The GerdQ score was calculated as the sum of these scores, giving a total score ranging from 0 to 18. A total GerdQ score \>7 is considered indicative of significant GERD symptoms (Jones R et al, Aliment Pharmacol Ther 2009).
Reflux esophagitis on post-POEM endoscopy3 months after treatmentThe severity of reflux esophagitis is graded according to the Los Angeles classification (Armstrong D et al, Gastroenterology 1996).
Total hospital costs of treatment per participantsThrough hospital stay after procedure, an average of 2-7 days

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026